QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

NASDAQ:KOOLCesca Therapeutics Stock Price, Forecast & News

$6.16
+0.51 (+9.03 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.65
Now: $6.16
$6.30
50-Day Range
$4.30
MA: $5.27
$6.21
52-Week Range
$2.10
Now: $6.16
$7.00
Volume706,435 shs
Average Volume96,680 shs
Market Capitalization$14.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.07
Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.
Read More
Cesca Therapeutics logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KOOL
CUSIPN/A
Phone916-858-5100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.67 million
Book Value$3.11 per share

Profitability

Net Income$-39,720,000.00

Miscellaneous

Employees53
Market Cap$14.91 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable
$6.16
+0.51 (+9.03 %)
(As of 08/10/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KOOL News and Ratings via Email

Sign-up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cesca Therapeutics (NASDAQ:KOOL) Frequently Asked Questions

How has Cesca Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Cesca Therapeutics' stock was trading at $3.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, KOOL stock has increased by 83.3% and is now trading at $6.16.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Cesca Therapeutics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cesca Therapeutics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Cesca Therapeutics
.

When is Cesca Therapeutics' next earnings date?

Cesca Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020.
View our earnings forecast for Cesca Therapeutics
.

How were Cesca Therapeutics' earnings last quarter?

Cesca Therapeutics Inc (NASDAQ:KOOL) announced its quarterly earnings results on Monday, May, 14th. The biotechnology company reported ($0.27) earnings per share for the quarter. The biotechnology company had revenue of $1.87 million for the quarter. Cesca Therapeutics had a negative return on equity of 77.30% and a negative net margin of 98.84%.
View Cesca Therapeutics' earnings history
.

What price target have analysts set for KOOL?

1 brokers have issued 12 month target prices for Cesca Therapeutics' stock. Their forecasts range from $7.50 to $7.50. On average, they anticipate Cesca Therapeutics' share price to reach $7.50 in the next year. This suggests a possible upside of 21.8% from the stock's current price.
View analysts' price targets for Cesca Therapeutics
.

Has Cesca Therapeutics been receiving favorable news coverage?

Media coverage about KOOL stock has been trending somewhat negative recently, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cesca Therapeutics earned a coverage optimism score of -1.9 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Cesca Therapeutics
.

Who are some of Cesca Therapeutics' key competitors?

What other stocks do shareholders of Cesca Therapeutics own?

Who are Cesca Therapeutics' key executives?

Cesca Therapeutics' management team includes the following people:
  • Dr. Xiaochun Xu M.B.A., Ph.D., Chairman, CEO & Pres (Age 48)
  • Mr. Jeff Cauble, Principal Financial & Accounting Officer (Age 46)
  • Mr. James Xu J.D., L.L.M., M.B.A., Director, Gen. Counsel, Sr. VP of Legal Affairs & Cybersecurity and Corp. Sec. (Age 48)
  • Mr. Philip H. Coelho, Chief Technology Officer (Age 75)
  • Ms. Haihong Zhu, Pres of ThermoGenesis

What is Cesca Therapeutics' stock symbol?

Cesca Therapeutics trades on the NASDAQ under the ticker symbol "KOOL."

How do I buy shares of Cesca Therapeutics?

Shares of KOOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cesca Therapeutics' stock price today?

One share of KOOL stock can currently be purchased for approximately $6.16.

How big of a company is Cesca Therapeutics?

Cesca Therapeutics has a market capitalization of $14.91 million and generates $9.67 million in revenue each year. The biotechnology company earns $-39,720,000.00 in net income (profit) each year or ($3.60) on an earnings per share basis. Cesca Therapeutics employs 53 workers across the globe.

What is Cesca Therapeutics' official website?

The official website for Cesca Therapeutics is www.cescatherapeutics.com.

How can I contact Cesca Therapeutics?

Cesca Therapeutics' mailing address is 2711 CITRUS ROAD, RANCHO CORDOVA CA, 95742. The biotechnology company can be reached via phone at 916-858-5100 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.